Corsair Pharma Announces Successful Completion of Preclinical Program for Its Treprostinil Prodrug Transdermal System ...
In the 1980s, when Stella Kourembanas, MD, began her career in neonatology, she cared for newborns with pulmonary ...
Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...
Background: The use of appetite suppressants in Europe has been associated with the development of primary pulmonary hypertension (PPH). Recently, fenfluramine appetite suppressants became widely ...
Implementing the ventilator-associated events (VAE) prevention protocol at Community Health Network has yielded remarkable ...
The leading Pulmonary Arterial Hypertension Companies such as Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, ...
Data show people with pulmonary arterial hypertension tend to stay in the hospital longer and have higher medical bills.
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...
Cash, cash equivalents and marketable securities as of December 31, 2024, were $294.5 million. As a result, we expect our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback